Seguridad y eficacia de pembrolizumab en niños y adultos jóvenes con linfoma de Hodgkin clásico
This study will examine the safety and efficacy of pembrolizumab (MK-3475) in combination with chemotherapy in children and young adults with newly diagnosed classical Hodgkin Lymphoma (cHL) who are slow early